Sponsor or institution
Clinical trials and research at Thetis Pharmaceuticals, LLC
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Resolvin-based therapy to help pancreatic cancer patients
A new therapy called TP-317 uses a natural anti-inflammatory molecule to help the body clear debris, boost anti-tumor immunity, and work with chemotherapy to slow pancreatic cancer.
-
Development of TP-317 for Ulcerative Colitis
A new therapy approach for ulcerative colitis aims to repair the intestinal lining and restore immune balance in people with UC, addressing a need for patients who don’t fully respond to current treatments.
-
Resolvin E1 (TP-317) treatment for pancreatic cancer
This project is developing a new drug called TP-317, based on a natural molecule (Resolvin E1), to reduce tumor growth and tumor-related inflammation in people with pancreatic cancer.
-
A new medicine, TP-317, for Ulcerative Colitis
This research focuses on creating an oral medicine called TP-317 to help people with ulcerative colitis manage their symptoms and stay in remission.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.